116 related articles for article (PubMed ID: 38159264)
1. Amelioration of Acute Radiation Dermatitis in Breast Cancer Patients by a Bioadhesive Barrier-Forming Gel (Episil): A Single-Center, Open, Parallel, Randomized, Phase I/II Controlled Trial.
Li Q; Feng S; Yu Z; Wang Y; Tian L; Geng H; Guo C; Ning F; Luo J; Liu C
Clin Pharmacol Ther; 2024 May; 115(5):1085-1091. PubMed ID: 38159264
[TBL] [Abstract][Full Text] [Related]
2. A Bioadhesive Barrier-Forming Oral Liquid Gel Improved Oral Mucositis and Nutritional Status in Patients With Head and Neck Cancers Undergoing Radiotherapy: A Retrospective Single Center Study.
Wei J; Wu J; Wang H; Wang B; Zhao T; Meng L; Dong L; Jiang X
Front Oncol; 2021; 11():617392. PubMed ID: 33692954
[TBL] [Abstract][Full Text] [Related]
3. Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer.
Ito K; Tokura S; Takazawa I; Yoshida N; Nakanishi T; Akiyama K; Onuma Y; Adachi T; Harada H; Nojima H; Miura M; Yoshimura R; Kabasawa Y
Heliyon; 2023 Jun; 9(6):e15869. PubMed ID: 37260888
[TBL] [Abstract][Full Text] [Related]
4. Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
Ueno T; Yatsuoka W; Ishiki H; Miyano K; Uezono Y
BMC Cancer; 2022 Jan; 22(1):90. PubMed ID: 35062896
[TBL] [Abstract][Full Text] [Related]
5. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
[TBL] [Abstract][Full Text] [Related]
6. A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.
Gil GOB; de Andrade WP; Diniz PHC; Cantidio FS; Queiroz IN; Gil MLBV; Almeida CAM; Caldeira PPR; Regalin M; Silva-Filho AL
Front Oncol; 2023; 13():1202544. PubMed ID: 37388233
[TBL] [Abstract][Full Text] [Related]
7. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
8. A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial.
Robijns J; Van Bever L; Hermans S; Claes M; Lodewijckx J; Lenaerts M; Tuts L; Vandaele E; Vinken E; Noé L; Verboven K; Maes A; Van de Velde AS; Bulens P; Bulens P; Van den Bergh L; Mebis J
Support Care Cancer; 2023 Oct; 31(12):625. PubMed ID: 37819539
[TBL] [Abstract][Full Text] [Related]
9. Local analgesic effect of a bioadhesive barrier-forming oral liquid in cancer patients with oral mucositis caused by chemotherapy and/or radiotherapy: a randomized multicenter, single-use, positive-controlled, open-label study.
Cheng Y; Qin SK; Chen YP; Dong LH; Sun XD; Yu SY; Wu SK
Onco Targets Ther; 2018; 11():8555-8564. PubMed ID: 30584316
[TBL] [Abstract][Full Text] [Related]
10. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
11. Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial).
Robijns J; Lodewijckx J; Puts S; Vanmechelen S; Van Bever L; Claes S; Pannekoeke L; Timmermans A; Noé L; Govers M; Van de Werf E; Maes A; Bulens P; Mebis J
Lasers Surg Med; 2022 Mar; 54(3):374-383. PubMed ID: 34481420
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
14. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
[TBL] [Abstract][Full Text] [Related]
15. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A
Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529
[TBL] [Abstract][Full Text] [Related]
16. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
[TBL] [Abstract][Full Text] [Related]
17. Effects of a bioadhesive barrier-forming oral liquid on pain due to radiation-induced oral mucositis in patients with head and neck cancer: A randomized crossover, preliminary study.
Soutome S; Yanamoto S; Kawashita Y; Yoshimatsu M; Murata M; Kojima Y; Funahara M; Umeda M; Saito T
J Dent Sci; 2021 Jan; 16(1):96-100. PubMed ID: 33384784
[TBL] [Abstract][Full Text] [Related]
18. Patients' view of the differences in topical creams for radiation dermatitis prevention. A pilot study of cosmetic properties.
Sabater S; Leon R; Esteban C; Añon JL; Arenas M
Rep Pract Oncol Radiother; 2019; 24(4):347-354. PubMed ID: 31198411
[TBL] [Abstract][Full Text] [Related]
19. Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.
Talakesh T; Tabatabaee N; Atoof F; Aliasgharzadeh A; Sarvizade M; Farhood B; Najafi M
Curr Radiopharm; 2022; 15(4):332-340. PubMed ID: 35747962
[TBL] [Abstract][Full Text] [Related]
20. Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.
Rayan G; Dawson LA; Bezjak A; Lau A; Fyles AW; Yi QL; Merante P; Vallis KA
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):154-61. PubMed ID: 12504048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
